Skip directly to page options Skip directly to A-Z link
Volume 29, Number 11—November 2023
Research

SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022

Richard A. TeranComments to Author , Alexandra Gagner, Stephanie Gretsch, Jeff Lauritsen, Daniel Galanto, Kelly Walblay, Peter Ruestow, Colin Korban, Massimo Pacilli, David Kern, Stephanie R. Black, and Irina Tabidze
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.A. Teran); Chicago Department of Public Health, Chicago, Illinois, USA (R.A. Teran, A. Gagner, S. Gretsch, J. Lauritsen, D. Galanto, K. Walblay, P. Ruestow, C. Korban, M. Pacilli, D. Kern, S.R. Black, I. Tabidze)

Main Article

Table 2

Effect of HIV status on SARS-CoV-2 reinfection, Chicago, Illinois, USA, January 1, 2020–May 31, 2022*

HIV status at first SARS-CoV-2 infection Total no. (%) persons, n = 453,587 (%) Total no. (%) events, n = 23,834 Unadjusted rate ratio (95% CI) p value Adjusted rate ratio (95% CI)† p value
PWH 2,886 (0.6) 192 (0.8) 1.32 (1.15–1.51) <0.0001 1.46 (1.27–1.68) <0.0001
PWOH 450,701 (99.4) 23,642 (99.2) Reference Reference

*Estimates describe exponentiated estimates from a Poisson regression model using the logarithm of person-time as the offset term. Bold text indicates statistical significance at p<0.05. PWH, persons with HIV; PWOH, persons without HIV. †Multivariable Poisson regression model controlled for the following covariates: age, sex at birth, ethnicity and race, region of residence, initial SARS-CoV-2 infection group, vaccination status at the time of first SARS-CoV-2 infection, vaccination type, and number of doses administered after the first SARS-CoV-2 infection.

Main Article

Page created: September 06, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external